Teleflex (TFX) Common Equity (2009 - 2026)
Teleflex's (TFX) quarterly Common Equity came in at $2.9 billion in Q2 2026, down 31.54% on a YoY basis from $4.2 billion in Q2 2025, and down 5.83% quarter-over-quarter from $3.1 billion in Q1 2026.
Analysis
Teleflex (TFX) Common Equity (2009 - 2026) Analysis & Trends
Teleflex (TFX) has reported Common Equity for 18 consecutive years, with $2.9 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity fell 31.54% year-over-year to $2.9 billion; the trailing twelve-month figure through Jun 2026 stood at $2.9 billion (down 31.54% YoY), and the FY2025 full-year result was $3.1 billion, down 26.96% from the prior year.
- Common Equity declined to $2.9 billion in Q2 2026 per TFX's latest filing, from $3.1 billion in the prior quarter.
- Across five years, Common Equity topped out at $4.6 billion in Q2 2024 and bottomed at $2.9 billion in Q2 2026.
- Historically, Common Equity has averaged $4.0 billion across 5 years, with a median of $4.1 billion in 2023.
- The sharpest annual moves came in 2022 and 2026: Common Equity increased 12.43% in 2022, then slumped 31.54% in 2026.
- Over 5 years, Common Equity stood at $4.0 billion in 2022, then increased by 10.42% to $4.4 billion in 2023, then slipped by 3.67% to $4.3 billion in 2024, then declined by 26.96% to $3.1 billion in 2025, then declined by 7.05% to $2.9 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $2.9 billion, $3.1 billion, and $3.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 50.85 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.99 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 25.17 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.72 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.60 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.62 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Teleflex | 5.76 Bn | 5.46 Bn | 331.71 Mn | 2.90 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.90 Bn |
| Mar 31, 2026 | 3.08 Bn |
| Dec 31, 2025 | 3.12 Bn |
| Sep 28, 2025 | 3.82 Bn |
| Jun 29, 2025 | 4.24 Bn |
| Mar 30, 2025 | 4.10 Bn |
| Dec 31, 2024 | 4.28 Bn |
| Sep 29, 2024 | 4.48 Bn |
| Jun 30, 2024 | 4.56 Bn |
| Mar 31, 2024 | 4.50 Bn |
| Dec 31, 2023 | 4.44 Bn |
| Oct 1, 2023 | 4.31 Bn |
| Jul 2, 2023 | 4.22 Bn |
| Apr 2, 2023 | 4.11 Bn |
| Dec 31, 2022 | 4.02 Bn |
| Sep 25, 2022 | 3.90 Bn |
| Jun 26, 2022 | 3.85 Bn |
| Mar 27, 2022 | 3.80 Bn |
| Dec 31, 2021 | 3.75 Bn |
| Sep 26, 2021 | 3.66 Bn |